Friday, July 24, 2026
Advertisement
Home Healthcare Markets News Reset Health and Pharmacy2U partner on weight loss

Reset Health and Pharmacy2U partner on weight loss

Reset Health has entered a strategic partnership with Pharmacy2U to deliver weight management support to patients using GLP-1 medications across the UK.

The collaboration, due to launch in the first quarter of 2026, will combine Pharmacy2U’s home delivery of GLP-1 medicines with Reset Health’s digital clinical support. Patients will receive medication directly through Pharmacy2U’s platform alongside access to Reset Health’s wraparound care, which includes monthly consultations, nutrition guidance, behavioural coaching and psychological support delivered via its digital health platform.

Reset Health, which focuses on personalised management of chronic disease, said the partnership is intended to provide end-to-end treatment for people living with obesity who are prescribed GLP-1 medicines.

CEO Oliver McGuinness said: ‘GLP-1s can transform the health of the nation, but we founded Reset Health because we knew treating chronic conditions requires more than medication alone. It needs continuous clinical support that is tailored to the needs of patients. This strategic partnership with Pharmacy2U is the foundation of how together we will transform obesity treatment in the UK. By combining rapid GLP-1 access with expert clinical wraparound care, we can help patients achieve sustained health benefits and behaviour change that meaningfully enables them in their everyday life.’

Recent research from the Nuffield Department of Primary Care Health Sciences found that patients coming off GLP-1 medication regained weight more rapidly than those who had undertaken dietary interventions alone, in some cases exceeding their original weight.

Current licensing requirements for GLP-1 medicines for obesity state that pharmacological treatment should be delivered alongside dietary, psychological and behavioural support, as well as increased physical activity.

Pharmacy2U, CEO Kevin Heath said: ‘We’re at a pivotal moment for the obesity management industry, marked by growing interest in GLP-1 treatments that pair medication with longer-term behavioural and clinical support. Together with Reset Health, we’re excited to be pioneering a new digitally-driven approach to medicated weight loss that aims to put control back in the hands of patients.’

Under the model, patients will be able to order repeat prescriptions through a one-click process on Pharmacy2U’s platform while being directed simultaneously to Reset Health’s clinical services. Support will be provided by a multidisciplinary team including clinicians, dietitians and health coaches.

McGuinness added: ‘The sales of obesity medicines are rapidly changing with the advent of new policies in how treatments are getting to patients under the US administration. This model has the potential to streamline the delivery of medication and if successful, with cost and efficiency pressures on healthcare systems around the world, this could be replicated in other international medication dispensation markets.’

Data gathered through the partnership will be evaluated to contribute to the clinical evidence base around holistic approaches to weight management and long-term outcomes.